FIELD: medicine.
SUBSTANCE: implant layers are presented in the form of congruent ellipsoids of rotation consisting of polymers and/or copolymers of glycosaminoglycans, lactic acid and polyvinylpyrrolidone; all drug-saturated layers are alternated with drug-unsaturated layers, while solubility of each implant layer is provided by hydrolysis of cross linkage and directly proportional to their number.
EFFECT: achieving and maintaining the required drug concentration in the vitreal cavity for the required period of time, no risk of damaging the intraocular structures with high-concentrated drug substances, reducing the intraoperative injury.
2 cl
| Title | Year | Author | Number |
|---|---|---|---|
| MULTILAYER BIODEGRADABLE OCULAR IMPLANT WITH DOSED DRUG RELEASE AND METHOD OF ITS MANUFACTURE | 2015 |
|
RU2620249C1 |
| METHOD FOR DRUG DELIVERY TO POSTERIOR EYEBALL SEGMENT STRUCTURES | 2015 |
|
RU2583599C1 |
| METHOD OF TREATING ATROPHIC AGE-RELATED MACULAR DEGENERATION | 2009 |
|
RU2521338C9 |
| METHOD FOR TREATING ATROPHIC AGE RELATED MACULAR DEGENERATION | 2009 |
|
RU2668371C2 |
| INTRAOCULAR IMPLANTS CONTAINING PROSTAMIDES | 2014 |
|
RU2666603C2 |
| INTRAOCULAR DRUG DELIVERY SYSTEMS | 2007 |
|
RU2440102C2 |
| METHOD FOR STIMULATING NEOVASCULARISATION OF RETINA AND OPTIC NERVE IN RABBITS | 2009 |
|
RU2408083C1 |
| BIODEGRADABLE DRUG DELIVERY SYSTEMS FOR LONG-TERM RELEASE OF PROTEIN | 2013 |
|
RU2676102C2 |
| DEXAMETHASONE CONJUGATE WITH SYNTHETIC STATISTICAL POLYPEPTIDE | 2020 |
|
RU2792146C2 |
| EYE IMPLANTAT PREPARED BY DOUBLE EXTRUSION METHOD | 2005 |
|
RU2389479C2 |
